Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease
- Authors
- Choi, Hee Soon; Kim, Hee Jin; Oh, Jin-Hwan; Park, Hyeong-Geun; Ra, Jeong Chan; Chang, Keun-A.; Suh, Yoo-Hun
- Issue Date
- Oct-2015
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- Human adipose-derived stem cells; 6-OHDA; Parkinson' s disease; Mitochondria
- Citation
- NEUROBIOLOGY OF AGING, v.36, no.10, pp.2885 - 2892
- Journal Title
- NEUROBIOLOGY OF AGING
- Volume
- 36
- Number
- 10
- Start Page
- 2885
- End Page
- 2892
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/10056
- DOI
- 10.1016/j.neurobiolaging.2015.06.022
- ISSN
- 0197-4580
- Abstract
- The treatment of Parkinson's disease (PD) using stem cells has long been the focus of many researchers, but the ideal therapeutic strategy has not yet been developed. The consistency and high reliability of the experimental results confirmed by animal models are considered to be a critical factor in the stability of stem cell transplantation for PD. Therefore, the aim of this study was to investigate the preventive and therapeutic potential of human adipose-derived stem cells (hASC) for PD and was to identify the related factors to this therapeutic effect. The hASC were intravenously injected into the tail vein of a PD mouse model induced by 6-hydroxydopamine. Consequently, the behavioral performances were significantly improved at 3 weeks after the injection of hASC. Additionally, dopaminergic neurons were rescued, the number of structure-modified mitochondria was decreased, and mitochondrial complex I activity was restored in the brains of the hASC-injected PD mouse model. Overall, this study underscores that intravenously transplanted hASC may have therapeutic potential for PD by recovering mitochondrial functions. (C) 2015 The Authors. Published by Elsevier Inc.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.